Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
HALOZYME THERAPEUTICS, INC. (HALO)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Assets |
| Cash and equivalents | 221.2 | 96.4 | | 147.2 | 90.9 | 117.8 | 118.7 | 491.7 |
| Short-term investments | | 179.2 | | 118.4 | 118.4 | 668.3 | 622.2 | 324.2 |
| Accounts receivable, net | 221.7 | 194.9 | | 233.3 | 189.4 | 113.8 | 91.0 | 112.1 |
| Inventories | 132.4 | 107.5 | | 103.3 | 97.6 | 47.8 | 53.9 | 56.0 |
| Other current assets | 190.5 | 37.0 | | 51.0 | 45.6 | 41.0 | 40.5 | 33.3 |
| Total current assets | 765.7 | 615.0 | | 653.2 | 541.9 | 988.7 | 926.3 | 1,017.3 |
| Property, plant, and equipment, net | 110.6 | 116.5 | | 67.7 | 68.5 | 15.5 | 15.6 | 16.8 |
| Intangibles | 511.0 | 528.8 | | 948.9 | 976.1 | | | |
| Goodwill | 416.8 | 416.2 | | 199.5 | 199.5 | | | |
| Other fixed assets | 18.4 | 25.2 | | 25.8 | 26.3 | 22.0 | 13.4 | 15.6 |
| Total assets | 1,810.4 | 1,699.4 | | 1,864.5 | 1,781.4 | 1,162.2 | 1,104.4 | 1,185.4 |
| |
| Accounts payable | 10.1 | 8.7 | | 18.2 | 12.2 | 1.3 | 1.5 | 3.3 |
| Accrued expenses | 241.7 | 189.5 | | 154.1 | 173.8 | 38.4 | 49.4 | 38.3 |
| Current portion of long-term debt | 0.0 | 0.0 | | 13.3 | 99.0 | 89.5 | 89.4 | 89.3 |
| Current portion of long-term debt | | | | 13.3 | 99.0 | 89.5 | 89.4 | 89.3 |
| Deferred revenues | | 3.2 | | 3.6 | 4.1 | 1.7 | | 2.2 |
| Other current liabilities | -135.5 | -109.6 | | -79.7 | -89.7 | -19.3 | -23.2 | -19.9 |
| Total current liabilities | 116.4 | 91.9 | | 109.4 | 199.5 | 111.7 | 117.1 | 113.2 |
| Long-term debt | 1,496.0 | 1,494.4 | | 1,491.2 | 2,025.7 | 1,665.7 | 1,663.9 | 1,662.2 |
| Other liabilities | 47.0 | 47.3 | | 37.2 | 11.6 | 2.2 | 0.5 | 4.1 |
| Total liabilities | 1,659.4 | 1,633.6 | | 1,637.8 | 2,236.8 | 1,779.6 | 1,781.6 | 1,779.5 |
| |
| Shareholders' equity [+] | 151.0 | 65.8 | | 226.8 | -455.4 | -617.4 | -677.2 | -594.0 |
| Paid-in capital | 12.1 | | | 13.2 | 271.2 | 261.7 | 256.3 | 407.2 |
| Retained earnings | 140.4 | 65.7 | | 85.5 | 23.9 | 1.2 | -58.9 | -125.7 |
| Tangible shareholders' equity | -776.8 | -879.2 | | -921.6 | -1,631.0 | -617.4 | -677.2 | -594.0 |
|